Lizhu Pharmaceutical (01513): Banxia Baishu Tianma Soup granules obtained the “Drug Registration Certificate”

Zhitong Finance App News, Lizhu Pharmaceutical (01513) issued an announcement. Recently, the company's subsidiary Sichuan Guangda Pharmaceutical Co., Ltd. (“Sichuan Everbright”) received the “Drug Registration Certificate” (certificate number: 2026S02612) issued by the State Drug Administration for the drug registration application of Banxia Baishu Tianma Soup granules.

The prescription for this drug is derived from “Medical Thoughts” by Cheng Guopeng in the Qing Dynasty, and has been included in the “Catalogue of Ancient Classic Famous Formulas (First Batch)” by the State Administration of Traditional Chinese Medicine. According to the original text of the book, this recipe is a classic remedy for phlegm and vertigo. Its function is to “relieve phlegm and wind, strengthen the spleen and remove moisture. It is used for evidence of obstruction by phlegm. Symptoms include dizziness, headache, chest tightness, nausea and vomiting, white tongue, and smooth pulse”. The core treatment idea of the prescription is to relieve phlegm, reduce wind, strengthen the spleen and remove moisture.

This prescription has accumulated a large number of medical cases. In modern times, many clinical and pharmacological experimental studies have also been carried out. The relevant research results have been quoted in medical textbooks and are highly recognized by the industry; as a commonly used clinical prescription in traditional Chinese medicine, it is widely used in the treatment of conditions such as dizziness, headache, nausea and vomiting.

As of the disclosure date of this announcement, the total direct investment in R&D expenses of Banxia Baishu Tianma Soup granules was approximately RMB 50,102 million.